UNSPSC 51172808: Amyl metacresol/benzocaine/myrrh/phenol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR900. This VA Drug Class (OR900) classifies this compound as belonging to the group DENTAL AND ORAL AGENTS, TOPICAL, OTHER.

UNSPSC 51172808 Amyl metacresol/benzocaine/myrrh/phenol is a Commodity code covering throat lozenges and oral antiseptic products supplied through state and local cooperative purchasing agreements for government health and correctional facilities. State and local procurement under this code flows primarily through multistate cooperative purchasing alliances and state pharmacy procurement offices, which consolidate demand across participating jurisdictions and authorized pharmaceutical wholesalers to negotiate volume pricing on generic and branded formulations. The work involves manufacturing and supply chain compliance, including FDA certification, cGMP and Drug Supply Chain Security Act (DSCSA) attestation, NDC tracking, wholesale distribution channel management, and contractual relationships with major pharmaceutical distributors.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal (S1070000015802) on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products including this commodity, with a March 26, 2026 response date and July 1, 2026 contract start. MMCAP serves participating state and local government facilities across Minnesota and Oregon. Vendors must maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, Morris & Dickson Co., LLC), carry commercial general liability insurance of $5,000,000 per occurrence, and commit to pricing structures including flat price, net pricing formats (NF30, NF60, NF90), or WAC-minus options. The contract runs two years for new vendors with optional extensions, or aligns with existing expiration dates through June 30, 2028 for incumbents. Evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing for contract term, and 5 percent each on administrative fee format compliance, EDI capability, and willingness to accept a 3 percent administrative fee.